Skip to main content

20/20 Biolabs, Inc.

AIDX
Exchange
Nasdaq
Industry
Services-Testing Laboratories
SEC CIK
0001139685

No open-market purchases or sales by 20/20 Biolabs, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $297.1K in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in 20/20 Biolabs, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
15
+8 vs. Q1 2026
Shares held
540.6K
+240.2K (+80.0%) vs. Q1 2026
Total value
$297.1K
−$267.7K (−47.4%) vs. Q1 2026
New holders
10
2 more added
Sold out
2
3 more reduced

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AIDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 15 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 7 institutionsQ2 2026: 15 institutions
Value heldQ2 2026: $297.1K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $564.8KQ2 2026: $297.1K
Institutions holding AIDX and their total value by quarter
QuarterHoldersValue
Q2 202615$297.1K
Q1 20267$564.8K
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding 20/20 Biolabs, Inc.; share changes are against Q1 2026.

Institutions holding AIDX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Cresset Asset Management, LLC240,122$132.0K0.00%−24,246−9.2%Reduced
HRT Financial LP89,273$49.0K0.00%+89,273New
Vanguard Fiduciary Trust Co52,087$28.6K0.00%+52,087New
Geode Capital Management, LLC49,141$27.0K0.00%+49,141New
Atlantic Union Bankshares Corp35,099$19.3K0.00%+35,099New
Vanguard Capital Management LLC24,530$13.5K0.00%+24,530New
Citadel Advisors LLC23,205$12.8K0.00%+6,978+43.0%Added
Bank of America Corp13,024$7.15K0.00%+13,024New
Susquehanna International Group, LLP10,014$5.50K0.00%+10,014New
McDonald Partners LLC2,800$1.54K0.00%+2,800New
Signaturefd, LLC767$4220.00%+767New
Morgan Stanley283$1560.00%+283New
Allworth Financial LP172$950.00%+142+473.3%Added
Toth Financial Advisory Corp100$550.00%−57−36.3%Reduced
UBS Group AG3$20.00%−8,311−100.0%Reduced
XTX Topco Ltd0$00.00%−10,329−100.0%Sold out
MAI Capital Management0$00.00%−1,000−100.0%Sold out